Skip to main content
. Author manuscript; available in PMC: 2020 May 15.
Published in final edited form as: Clin Cancer Res. 2009 May 5;15(10):3617–3623. doi: 10.1158/1078-0432.CCR-08-3071

Table 1.

Toxicity possibly or probably related to treatment with enzastaurin (N = 22)

Toxicity Grade 1-2 Grade 3-4 Grade 5
Thrombocytopenia 6 (27%) 5 (23%) 0
QTc prolongation 5 (23%) 2 (9%)* 0
Elevated AST 9 (41%) 0 0
Elevated ALT 5 (23%) 1 0
Intracranial hemorrhage 0 0 1
Hypermagnesemia 1 0 0
Proteinuria 1 0 0
Hematuria 1 0 0
Nausea 1 0 0

Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase.

*

Cases were transient, asymptomatic, and required no intervention or therapy.

Occurred in the setting of grade 3 thrombocytopenia.